“Pinning all our hopes on a vaccine that works immediately is not the right strategy,” Dr. William Haseltine, a former professor at Harvard University’s medical and public health schools, told CNN’s Wolf Blitzer. Haseltine said a broad public health strategy is a better way to contain the spread of the virus along with the help… Read More »
According to a British observational study1 posted July 6, 2020, on the preprint server medRxiv, ultraviolet (UV) radiation exposure appears to lower COVID-19 mortality rates. As reported by News Medical Life Sciences,2 environmental factors such as temperature, humidity and UV irradiation are known to play a role in other infectious diseases, including seasonal influenza, so… Read More »
Department of Health WITHDRAWS official UK Coronavirus daily death toll of 114 after it emerges nobody in England is ever counted as cured Department of Health figures show 82 Britons are now succumbing to the life-threatening infection each day The seven-day average was 74 last Friday. More than 1,000 people died each day during the peak… Read More »
Health Secretary Matt Hancock has called for an urgent review into how coronavirus deaths have been recorded in England. It follows confirmation from Public Health England that reported deaths may have included people who tested positive months before they died. The other UK nations only include those who die within 28 days of a positive… Read More »
People with dementia have suffered an alarming deterioration in their health and wellbeing during the Covid-19 pandemic, a stark new report warns today. EOPLE with dementia have suffered an alarming deterioration in their health and wellbeing during the Covid-19 pandemic, a stark new report warns today. Lockdown and the closure of vital day services and… Read More »
On the heels of early positive COVID-19 vaccine data, the CEOs at BioNTech and Pfizer are gearing up for a late-stage trial and talking up potential approvals later this year. In separate interviews this week, Pfizer CEO Albert Bourla and BioNTech CEO Ugur Sahin said their mRNA vaccine candidate could be ready to submit to regulators in the fall or winter, respectively, pending success in… Read More »